Approaches to the identification of new nonhormonal targets for male contraception.
Fertility control is a global health issue with major personal and societal impact. Although, currently, there are several different options for contraception, the technologies behind these are antiquated, and the options for male-based contraception (i.e., withdrawal, condom and vasectomy) are inadequate. The genomic, proteomic and bioinformatic revolutions have provided new tools and new targets for contraceptive development, and the results of such approaches have identified gene products that play critical roles in male reproduction, thus expanding the array of potential targets for novel and innovative male-based contraceptives. This article will review the types of targets being considered in the development of nonhormonal male contraceptives and the technologies used to identify and validate these targets.
Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. kopfgs@gmail.com
Gregory S
GS
Kopf
D003267:Contraception / Q000379:methods*; D003272:Contraceptive Agents, Male / Q000494:pharmacology* / Q000627:therapeutic use; D015195:Drug Design; D004822:Epididymis / Q000187:drug effects; D006801:Humans; D008297:Male; D013091:Spermatogenesis / Q000187:drug effects; D013737:Testis / Q000187:drug effects
D003272:Contraceptive Agents, Male